Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease

Christopher Exley1, Emily House, Joanna F Collingwood

  • 1The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire, UK. c.exley@chem.keele.ac.uk

Insights

Researchers observed amyloid-beta (Abeta)42 forming spherulites under near-physiological conditions, mimicking structures found in Alzheimer

Area of Science:

  • Biochemistry
  • Neuroscience
  • Materials Science

Background:

  • Amyloidogenic proteins like insulin can form spherulites in vitro.
  • Amyloid spherulites are ordered fibril arrays with a Maltese cross pattern.
  • The role of spherulites in Alzheimer's disease (AD) is unclear, though some plaques show similar patterns.

Purpose of the Study:

  • To investigate the in vitro formation of amyloid-beta (Abeta)42 spherulites.
  • To explore the potential role of copper in Abeta42 aggregation and spherulite formation.
  • To compare in vitro formed Abeta42 spherulites with structures found in AD brain tissue.

Main Methods:

  • Disruption of Abeta42 beta-sheet conformation with excess copper.
  • Incubation of modified Abeta42 at 37°C for up to 9 months.
  • Analysis of Abeta42 structures using polarizing microscopy and synchrotron X-ray fluorescence.

Main Results:

  • Formation of Abeta42 spherulites (5-20 micrometers) with Maltese cross patterns under near-physiological conditions.
  • Observation of similar spherulitic structures in Alzheimer's disease brain tissue.
  • Correlation between spherulite location in AD tissue and elevated copper concentrations.

Conclusions:

  • In vitro Abeta42 spherulites resemble in vivo structures found in AD brain.
  • This supports the hypothesis that senile plaques and spherulites in AD are similar.
  • Copper may play a crucial role in the ultimate formation of these structures in Alzheimer's disease.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...